CINCINNATI, Dec. 18, 2023 (GLOBE NEWSWIRE) Blue Water Biotech, Inc. (NASDAQ:BWV) ("BWB" or the "Company") today announced the acquisition of Proteomedix AG, a private, commercial-stage diagnostics oncology
Blue Water Vaccines (BWV) to Acquire a Commercial Stage Oncology Company streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
JUPITER, Fla., Feb. 4, 2021 /PRNewswire/ Marizyme, Inc. (OTCQB:MRZM), a publicly traded global biotechnology company developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications, announced today that it has named veteran business executive Julie Kampf as an Independent Member of its Board of Directors. Ms. Kampf will provide invaluable guidance as an Independent Member of Marizyme s Board of Directors as the company accelerates clinical and commercial development and puts a concurrent emphasis on revenue generation in the year ahead, said Dr. Neil J. Campbell, Marizyme s CEO, President and Board Member. She has a stellar reputation as a global business executive and thought leader in the life science arena.